-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Ironwood Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Ironwood Pharmaceuticals Inc Operating Income (Loss) for the quarter ending September 30, 2024 was $25.6M, a 35.9% decline year-over-year.
- Ironwood Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was $99.2M.
- Ironwood Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was -$945M, a 478% decline from 2022.
- Ironwood Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was $250M, a 7.78% increase from 2021.
- Ironwood Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was $232M, a 62.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)